Red List:Official warnings and scam reports, with sourcesCheck a link
Regulatory warningOfficial actionRegulatory note

BioMD Plus LLC

Received an FDA warning letter over CBD and delta-8 THC products marketed with mental-health and pain claims

This entry is about the United States — not the country you picked in the header.

According to U.S. Food and Drug Administration, May 4, 2022 · Read the source · +1 more

Where
Georgia, United States
First reported
Last checked

Summary

BioMD Plus LLC of Marietta, Georgia, received an FDA warning letter dated May 4, 2022, one of five letters the agency issued that day over delta-8 THC and CBD products. The FDA says the company's website and social media promoted CBD oil, capsules, gummies, a pain cream and a pet CBD oil, as well as delta-8 THC gummies and vape cartridges. According to the letter, the marketing linked the products to treating or relieving conditions such as anxiety, depression, bipolar disorder, PTSD, schizophrenia, dementia, arthritis, seizures and chronic pain, including claims made for pets. The FDA said these claims made the products unapproved new drugs for people and animals, that the products were misbranded because they lacked adequate directions for use, and that the edibles were adulterated. The company was asked to respond within 15 working days. Its current status was not verified.

What the source found

  • The FDA reviewed biomdplus[.]com and the company's Twitter, Facebook and Instagram accounts.
  • Products cited: CBD oil, CBD capsules, vegan CBD gummies, CBD pain relief cream, delta-8 THC gummies, a delta-8 THC vape cartridge and a pet CBD oil.
  • According to the letter, the claims covered anxiety, depression, bipolar disorder, PTSD, OCD, schizophrenia, dementia, arthritis, seizures, insomnia and chronic pain.
  • The FDA cited unapproved new drugs, misbranding and adulterated food.

Products named

  • CBD oils, capsules and gummies
  • CBD topicals
  • delta-8 THC gummies
  • delta-8 THC vape cartridges
  • CBD pet products

Timeline

  1. FDA warning letter issued and publicly announced

Sources

  1. Regulator

    U.S. Food and Drug Administration · May 4, 2022

    BioMD Plus LLC - 618460 - 05/04/2022
  2. Regulator

Wording on this page follows the sources. Found an error? See the corrections process in our editorial policy.

Status notes

Current status not verified. No close-out letter was noted on the FDA letter page when checked in September 2026.

Comments

No comments yet.

Comments are read by a moderator before they’re published.

Report a seller

Tell us what happened

Every report is read by a person. You don’t need to prove anything, and we never publish your name.

What happens next
  • A moderator reads your report and checks the link against the Red List and our seller records.
  • We look for an authoritative source — a regulator, court, police or consumer-protection finding.
  • When a source confirms it, your report is linked to a Red List entry. Your name and contact details stay private.

Self-check · 2 minutes · private

Is cannabis becoming a problem for you?

Eight questions from CUDIT-R, a screening test used by clinicians. Your answers never leave this page.